These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Up-date in the renin-angiotensin system. 1) Peculiarities in children]. Goţia S Rev Med Chir Soc Med Nat Iasi; 1981; 85(4):565-9. PubMed ID: 25528797 [No Abstract] [Full Text] [Related]
4. Pathogenic role of the renin-angiotensin system in modulating radiation-induced late effects. Robbins ME; Diz DI Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):6-12. PubMed ID: 16377409 [No Abstract] [Full Text] [Related]
5. Comparison of renin-angiotensin to calcium channel blockade in renal disease. Tikkanen I; Johnston CI Kidney Int Suppl; 1997 Dec; 63():S19-22. PubMed ID: 9407414 [TBL] [Abstract][Full Text] [Related]
6. Effect of angiotensin II antagonism on the regression of kidney disease in the rat. Remuzzi A; Gagliardini E; Donadoni C; Fassi A; Sangalli F; Lepre MS; Remuzzi G; Benigni A Kidney Int; 2002 Sep; 62(3):885-94. PubMed ID: 12164870 [TBL] [Abstract][Full Text] [Related]
8. Combination inhibition of the renin-angiotensin system: is more better? Krause MW; Fonseca VA; Shah SV Kidney Int; 2011 Aug; 80(3):245-55. PubMed ID: 21633407 [TBL] [Abstract][Full Text] [Related]
9. Progressive chronic nephropathy. With special emphasis on the influence of angiotensin converting enzyme inhibition. Kamper AL Dan Med Bull; 1998 Apr; 45(2):181-94. PubMed ID: 9587702 [No Abstract] [Full Text] [Related]
10. Effectively targetting the renin-angiotensin-aldosterone system in cardiovascular and renal disease: rationale for using angiotensin II receptor blockers in combination with angiotensin-converting enzyme inhibitors. Weinberg MS; Weinberg AJ; Zappe DH J Renin Angiotensin Aldosterone Syst; 2000 Sep; 1(3):217-33. PubMed ID: 11881029 [No Abstract] [Full Text] [Related]
11. "As time goes by": angiotensin II-mediated transactivation of the EGF receptor comes of age. Wolf G Nephrol Dial Transplant; 2005 Oct; 20(10):2050-3. PubMed ID: 16166749 [No Abstract] [Full Text] [Related]
12. Combined blockade of the renin-angiotensin system with angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists. Azizi M; Ménard J Circulation; 2004 Jun; 109(21):2492-9. PubMed ID: 15173039 [No Abstract] [Full Text] [Related]
13. The COOPERATE trial. Vogt L; Laverman GD; de Zeeuw D; Navis G Lancet; 2003 Mar; 361(9362):1055-6. PubMed ID: 12660079 [No Abstract] [Full Text] [Related]
15. [Lights and shadows on single and dual RAAS blockade]. Cavalli A; Del Vecchio L; Locatelli F G Ital Nefrol; 2010; 27(5):477-89. PubMed ID: 20922679 [TBL] [Abstract][Full Text] [Related]
16. Angiotensin II type 1 receptor blocking agents in regression of cardiac hypertrophy--how and why? Paul B; Goyal RK Indian Heart J; 2000; 52(1):19-22. PubMed ID: 10820928 [No Abstract] [Full Text] [Related]
17. Angiotensin, ACE inhibition and the kidney. Venice, Italy, September 1985. Proceedings. Kidney Int Suppl; 1987 May; 20():S1-234. PubMed ID: 3037157 [No Abstract] [Full Text] [Related]
18. [Blockade of the renin-angiotensin system. ACE inhibitors, angiotensin II antagonists or both?]. Karlsen FM; Kamper AL Ugeskr Laeger; 2003 Oct; 165(42):4006-9. PubMed ID: 14610833 [No Abstract] [Full Text] [Related]
19. Brief pharmacological intervention in experimental radiation nephropathy. Moulder JE; Fish BL; Cohen EP Radiat Res; 1998 Nov; 150(5):535-41. PubMed ID: 9806595 [TBL] [Abstract][Full Text] [Related]